Quick Answer
Insight Molecular Diagnostics Inc. reported Total Revenue of $4.06 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +115.6% in Total Revenue from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $16.0 thousand | Q2 2020: $143.0 thousand | Q3 2020: $555.0 thousand | Q4 2020: $503.0 thousand | Q1 2021: $1.12 million | Q2 2021: $2.03 million | Q3 2021: $984.0 thousand | Q4 2021: $3.59 million | Q1 2022: $380.0 thousand | Q2 2022: $237.0 thousand | Q3 2022: $67.0 thousand | Q1 2023: $297.0 thousand | Q2 2023: $463.0 thousand | Q3 2023: $429.0 thousand | Q1 2024: $176.0 thousand | Q2 2024: $104.0 thousand | Q3 2024: $115.0 thousand | Q1 2025: $2.14 million | Q2 2025: $518.0 thousand | Q3 2025: $260.0 thousand.
- Over the full 6 years of available data (2020 to 2025), Insight Molecular Diagnostics Inc.'s Total Revenue has grown by 233.5%.
- Historical annual values: Fiscal year 2025: $4.06 million | Fiscal year 2024: $1.88 million | Fiscal year 2023: $1.50 million | Fiscal year 2022: $958.0 thousand | Fiscal year 2021: $2.20 million | Fiscal year 2020: $1.22 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: